Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Frontiers in endocrinology ; h5-index 55.0

Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved as understanding of disease pathophysiology improved, methods of imaging and assessing DR changed, and effective treatments were developed. Current DR classification systems are effective, and have been the basis of major research trials and clinical management guidelines for decades. However, with further new developments such as recognition of diabetic retinal neurodegeneration, new imaging platforms such as optical coherence tomography and ultra wide-field retinal imaging, artificial intelligence and new treatments, our current classification systems have significant limitations that need to be addressed. In this paper, we provide a historical review of different classification systems for DR, and discuss the limitations of our current classification systems in the context of new developments. We also review the implications of new developments in the field, to see how they might feature in a future, updated classification.

Yang Zhengwei, Tan Tien-En, Shao Yan, Wong Tien Yin, Li Xiaorong

2022

artificial intelligence, classification, deep learning, diabetic retinopathy, imaging technology, pathophysiology, quantitative assessment, severity staging system